AXGN · Axogen, Inc.

$41.15 +0.01 (+0.02%)

Market Cap

$2.19B

53.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Dale	CEO	$775,865	—	$7,342,895	—	$906,133	$22,561	$9,047,454
Marc Began	Executive Vice President and GC	$439,051	—	$2,290,750	—	$307,660	$25,969	$3,063,430
Jens Kemp	CMO	$395,205	—	$1,582,700	—	$276,936	$24,365	$2,279,206
Erick DeVinney	VP of Peripheral Nerve Science and Clinical Innovation	$414,607	—	$1,582,700	—	$242,110	$22,324	$2,261,741
Lindsey Hartley	CFO	$395,065	—	$1,302,420	—	$217,503	$20,238	$1,935,226
Nir Naor	Chief Financial Officer	$228,186	—	—	—	—	$43,358	$271,544

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Dale	CEO	$303,163	—	$8,025,000	—	$509,493	$10,266	$8,847,922
Former CFO	—	$475,140	—	$2,073,000	—	$477,801	$22,941	$3,048,882
Nir Naor	CFO	$475,140	—	$2,073,000	—	$477,801	$22,941	$3,048,882
Karen Zaderej	CEO	$439,585	—	—	—	$735,420	$1,300,622	$2,475,627
Erick DeVinney	VP of Peripheral Nerve Science and Clinical Innovation	$400,318	—	$1,508,492	—	$335,467	$22,290	$2,266,567
Marc Began	Executive Vice President and GC	$423,919	—	$973,992	—	$426,293	$23,370	$1,847,574
Jens Kemp	CMO	$374,419	—	$973,992	—	$376,496	$21,064	$1,745,971

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen Zaderej	CEO	$700,000	—	$3,159,140	$886,050	$763,700	$25,791	$5,534,681
Peter Mariani	CFO	$473,000	—	$1,038,712	$467,775	—	$932,271	$2,911,758
Angelo Scopelianos	Chief Research & Development Officer	$419,056	—	$695,507	$386,100	$228,595	$90,221	$1,819,479
Michael Donovan	Vice President of Operations	$375,000	—	$649,195	$314,325	$204,563	$23,810	$1,566,893
Erick DeVinney	VP of Peripheral Nerve Science and Clinical Innovation	$348,000	—	$631,001	$316,800	$189,834	$20,062	$1,505,697
Chief Innovation	Officer	$348,000	—	$631,001	$316,800	$189,834	$20,062	$1,505,697
Nir Naor	CFO	$36,438	—	—	—	$23,853	—	$60,291
Former CFO	—	$36,438	—	—	—	$23,853	—	$60,291
Marc Began	Executive Vice President and GC	—	—	—	—	—	—	—
Chief Marketing	Officer	—	—	—	—	—	—	—
Michael Dale	CEO	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen Zaderej	CEO	$673,992	—	$2,125,120	$1,420,989	$161,998	$16,193	$4,398,292
Peter Mariani	CFO	$457,259	—	$1,121,596	$461,794	$60,438	$14,801	$2,115,888
Eric Sandberg	Former Chief Commercial Officer	$214,928	—	$843,862	$271,380	—	$581,901	$1,912,071
Angelo Scopelianos	Chief Research & Development Officer	$406,850	—	$554,017	$181,826	$48,878	$85,184	$1,267,797
Bradley Ottinger	General Counsel	$389,534	—	$573,779	$192,122	$46,792	$13,592	$1,215,819
Michael Donovan	Vice President of Operations	$349,194	—	$510,450	$159,132	$42,022	$14,802	$1,075,600
Erick DeVinney	VP of Peripheral Nerve Science and Clinical Innovation	—	—	—	—	—	—	—
Chief Innovation	Officer	—	—	—	—	—	—	—
Michael Dale	CEO	—	—	—	—	—	—	—
Marc Began	Executive Vice President and GC	—	—	—	—	—	—	—
Nir Naor	CFO	—	—	—	—	—	—	—
Chief Marketing	Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen Zaderej	CEO	$651,200	—	$3,356,055	$847,962	$499,347	$6,011	$5,360,575
Peter Mariani	CFO	$438,257	—	$1,275,510	$675,270	$186,850	$71,296	$2,647,183
Angelo Scopelianos	Chief Research & Development Officer	$394,659	—	$591,753	$376,380	$151,422	$67,913	$1,582,127
Former Chief Commercial	Officer	$364,000	—	$740,214	$260,145	$153,400	$11,600	$1,529,359
Eric Sandberg	Former Chief Commercial Officer	$364,000	—	$740,214	$260,145	$153,400	$11,600	$1,529,359
Maria Martinez	—	$352,040	—	$767,397	$260,145	$134,982	$11,600	$1,526,164
Michael Donovan	Vice President of Operations	—	—	—	—	—	—	—
Bradley Ottinger	General Counsel	—	—	—	—	—	—	—
Nir Naor	CFO	—	—	—	—	—	—	—
Erick DeVinney	VP of Peripheral Nerve Science and Clinical Innovation	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen Zaderej	CEO	$560,835	—	$2,161,653	$351,276	$966,971	$10,747	$4,051,482
Peter Mariani	CFO	$361,800	—	$502,623	$188,623	$434,032	—	$1,487,078
Bradley Ottinger	General Counsel	$332,550	$25,000	$442,260	$318,920	$150,244	$35,852	$1,304,826
Eric Sandberg	Former Chief Commercial Officer	$315,000	—	$482,273	$105,120	$298,661	$92,964	$1,294,018
Former Chief Commercial	Officer	$315,000	—	$482,273	$105,120	$298,000	$92,964	$1,293,357
Angelo Scopelianos	Chief Research & Development Officer	$332,550	—	$398,265	$105,120	$286,685	$76,259	$1,198,879
Brad Ottinger	General Counsel	$175,985	$25,000	$442,260	$318,920	$150,244	$35,852	$1,148,261
Chief Human Resources	Officer	$304,650	—	$355,215	$105,120	$262,589	$11,400	$1,038,974
Michael Donovan	Vice President of Operations	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Sandberg	Former Chief Commercial Officer	$323,077	—	$282,975	$373,050	$122,709	$11,631	$1,113,442
Karen Zaderej	CEO	$605,000	—	—	—	$382,602	$12,361	$999,963
Angelo Scopelianos	Chief Research & Development Officer	$357,700	—	—	—	$119,758	$76,678	$554,136
Peter Mariani	CFO	$390,100	—	—	—	$145,117	$12,815	$548,032
Chief Human Resources	Officer	$326,900	—	—	—	$121,607	$11,200	$459,707

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Karen Zaderej	CEO	$575,000	—	$2,065,568	$593,418	$419,175	$12,027	$3,665,188
Angelo Scopelianos	Chief Research & Development Officer	$127,615	—	$693,797	$625,826	$50,199	$23,187	$1,520,624
Peter Mariani	CFO	$361,200	—	$491,711	$415,492	$157,989	$12,615	$1,439,007

Key facts CIK 805928 CUSIP 05463X106 13F (30d) 36 filings 36 filers Visit website Investor relations